Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis

CompletedOBSERVATIONAL
Enrollment

4,613

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 5, 2021

Study Completion Date

September 5, 2021

Conditions
Psoriasis
Trial Locations (1)

Unknown

Henri Mondor Hospital, Créteil

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

French Health Products Safety Agency

OTHER_GOV

collaborator

Société de Dermatologie Française

OTHER

collaborator

Janssen, LP

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

AbbVie

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER